![Greg Fredde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Greg Fredde currently works as a Director at Light Line Medical, Inc.
Actieve functies van Greg Fredde
Bedrijven | Functie | Begin |
---|---|---|
Light Line Medical, Inc.
![]() Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Light Line Medical, Inc.
![]() Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Health Technology |